Almost All Cancer Patients Respond Well to COVID-19 Vaccines
TUESDAY, July 6, 2021 (HealthDay News) — Most cancer patients have a good immune response to COVID-19 mRNA vaccines, new research shows. Two of the three approved vaccines in the United States — Pfizer and Moderna — are mRNA vaccines. Researchers assessed 131 cancer patients and found that 94% developedContinue Reading